Note 8, Stock Based Compensation (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |
Dec. 31, 2016 | Mar. 31, 2017 | Mar. 31, 2016 | Sep. 30, 2016 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | 236,034 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 44.60 | | | $ 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share | | | | 0 |
Share-based Compensation | | $ 22,000,000 | $ 6,000,000 | |
Adient Share Bifurcation | 1 | | | |
JCI Share Bifurcation | 10 | | | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | 1 year 4 months | | | |
Former Parent Outstanding Remaining Contractual Life | | 5 years | | |
Former Parent Outstanding Aggregate Intrinsic Value | $ 16,000,000 | | | |
Adient Outstanding Remaining Contractual Life | | 4 years 5 months | | |
Adient Outstanding Aggregate Intrinsic Value | 9,000,000 | | | |
Former Parent Exercisable Remaining Contractual Life | | 4 years 5 months | | |
Former Parent Exercisable Aggregate Intrinsic Value | 16,000,000 | | | |
Adient Exercisable Remaining Contractual Life | | 3 years 11 months | | |
Adient Exercisable Aggregate Intrinsic Value | $ 8,000,000 | | | |
Employee Stock Option [Member] | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ 35.26 | | | $ 32.42 |
Weighted Average Price Exercised Prior to 10.31.2016 | $ 27.22 | | | |
Weighted Average Options Forfeited prior to 10.31.2016 | 31.71 | | | |
Weighted Average Options Converted Prior to 10.31.2016 | 33.28 | | | |
Weighted Average Options Converted at Separation | $ 32.49 | | | |
Options Forfeited prior to 10.31.2016 | 3,330 | | | |
Options Converted Prior to 10.31.2016 | 169,125 | | | |
optionsconvertedatseparation | 2,495,543 | | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options | | | | 2,336,028 |
Adient Weighted Average Exercisable | $ 31.92 | | | |
Adient Weighted Average Outstanding | $ 33.66 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | 1,665,093 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ 29.79 | | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price | | 5 years | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 25,000,000 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | 2,861 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) | (827,589) | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $ 25.88 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 0 | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ 26.95 | | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | 1,394,152 | | | |
Options Exercised Prior to 10.31.2016 | 6,280 | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 0 | | | |
Former Parent Weighted Average Outstanding | $ 35.50 | | | |
formerparentoptionsoutstanding | 1,445,791 | | | |
Adientoutstandingoptions | 219,302 | | | |
Former Parent Weighted Average Exercisable | $ 29.44 | | | |
formerparentoptionsexercisable | 1,199,479 | | | |
adientoptionsexercisable | 194,673 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 4 years 3 months | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ 24,000,000 | | | |
Restricted Stock [Member] | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 45.19 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 2,258,199 | | | 1,320,448 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | (1,162,213) | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share | $ 76,000,000 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 45.44 | | | $ 46.42 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 50.31 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 280,796 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | (78,692) | | | |
Adientoutstandingoptions | 1,219,064 | | | |
Weighted Average Options Converted Prior to 10.31.2016 | $ 48.06 | | | |
Options Converted Prior to 10.31.2016 | 135,026 | | | |
Weighted Average Options Converted at Separation | $ 46.57 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 45.31 | | | |
optionsconvertedatseparation | 1,455,474 | | | |
Former Parent Weighted Average Remaining Contractual Term | $ 45.58 | | | |
formerparentoptionsoutstanding | 1,039,135 | | | |
Adient Weighted Average Remaining Contractual Term | $ 45.42 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | 2 years 3 months 18 days | | | |
Stock Appreciation Rights (SARs) [Member] | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 650,677 | | | 654,694 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 31.10 | | | $ 31.26 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $ 650,677 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 34.74 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | (4,979) | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Exercisable | $ 27.93 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Exercisable | 613,373 | | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Exercisble Remaining Contractual Term | | 3 years 9 months | | |
Former Parent Weighted Average Exercisable | $ 27.60 | | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price | | 4 years | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $ 11,000,000 | | | |
formerparentoptionsexercisable | 556,725 | | | |
Former Parent Exercisable Remaining Contractual Life | | 3 years 9 months | | |
Former Parent Exercisable Aggregate Intrinsic Value | $ 8,000,000 | | | |
Adient Weighted Average Exercisable | $ 31.13 | | | |
adientoptionsexercisable | 56,648 | | | |
Adient Exercisable Remaining Contractual Life | | 3 years 9 months | | |
Adient Exercisable Aggregate Intrinsic Value | $ 3,000,000 | | | |
Adient Outstanding Remaining Contractual Life | | 4 years | | |
Adient Outstanding Aggregate Intrinsic Value | 3,000,000 | | | |
Weighted Average Price Exercised Prior to 10.31.2016 | $ 29.68 | | | |
Options Exercised Prior to 10.31.2016 | (9,470) | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Number of Shares, Period Increase (Decrease) | (31,281) | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 49.44 | | | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options | 613,373 | | | |
Former Parent Outstanding Remaining Contractual Life | | 4 years | | |
Former Parent Outstanding Aggregate Intrinsic Value | $ 8,000,000 | | | |
SARS Weighted Average Options Converted Prior to 10.31.2016 | $ 33.16 | | | |
SARS Converted Prior to 10.31.2016 | 41,713 | | | |
SARS Weighted Average Options Converted at Separation | $ 31.40 | | | |
SARSconvertedatseparation | 686,937 | | | |
SARS Former Parent Weighted Average Outstanding | $ 31.01 | | | |
SARS formerparentoptionsoutstanding | 590,638 | | | |
SARS Adient Weighted Average Outstanding | $ 32.03 | | | |
SARS Adientoutstandingoptions | 60,039 | | | |
Performance Shares [Member] | | | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | | |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ 44.60 | | | |
PSU Weighted Average Price Converted 10.31.2016 | $ 0 | | | |
PSU converted 10.31.2016 | 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | $ 236,034 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 0 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ 0 | | | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 24,000,000 | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | 2 years 7 months | | | |